These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32703782)

  • 1. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review.
    Aragona P; Giannaccare G; Mencucci R; Rubino P; Cantera E; Rolando M
    Br J Ophthalmol; 2021 Apr; 105(4):446-453. PubMed ID: 32703782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Topics in Dry Eye Disease.
    Chiaradia PA; Zeman Bardeci LA; Dankert S; Mendaro MO; Grzybowski A
    Curr Pharm Des; 2017; 23(4):608-623. PubMed ID: 27928967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DRY EYE DISEASE. A REVIEW.
    Zemanová M
    Cesk Slov Oftalmol; 2021; 77(3):107–119. PubMed ID: 34107689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry eye disease in strabismus patients: Does eye deviation harm ocular surface?
    Giannaccare G; Versura P; Sebastiani S; Fariselli C; Pellegrini M; Campos E
    Med Hypotheses; 2018 Feb; 111():15-18. PubMed ID: 29406988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.
    Baudouin C; Messmer EM; Aragona P; Geerling G; Akova YA; Benítez-del-Castillo J; Boboridis KG; Merayo-Lloves J; Rolando M; Labetoulle M
    Br J Ophthalmol; 2016 Mar; 100(3):300-6. PubMed ID: 26781133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconsidering the central role of mucins in dry eye and ocular surface diseases.
    Baudouin C; Rolando M; Benitez Del Castillo JM; Messmer EM; Figueiredo FC; Irkec M; Van Setten G; Labetoulle M
    Prog Retin Eye Res; 2019 Jul; 71():68-87. PubMed ID: 30471351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.
    Jeyabalan N; Pillai AM; Khamar P; Shetty R; Mohan RR; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1285-1291. PubMed ID: 37026260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear biomarkers in dry eye disease: Progress in the last decade.
    Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of blinking exercises in dry eye disease.
    Kim AD; Muntz A; Lee J; Wang MTM; Craig JP
    Cont Lens Anterior Eye; 2021 Jun; 44(3):101329. PubMed ID: 32409236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of dry eye disease and novel therapeutic targets.
    Messmer EM
    Exp Eye Res; 2022 Apr; 217():108944. PubMed ID: 35077753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework.
    Tong L; Lim L; Tan D; Heng WJ; Lim J; Chan C; Arundhati A; Tan A;
    Asia Pac J Ophthalmol (Phila); 2021 Nov; 10(6):530-541. PubMed ID: 34759232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.